TMO position history
The shares of Thermo Fisher Scientific (TMO) that Egerton Capital (UK) LLP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2023 Q1: 106,751 shares, $62M, 0.66% of portfolio, New
- 2023 Q2: 562,479 shares, $293M, 3.0% of portfolio, Add +426.9%
- 2023 Q3: not held, Exit
- 2023 Q4: not held
- 2024 Q1: not held
- 2024 Q2: not held
- 2024 Q3: not held
- 2024 Q4: not held
- 2025 Q1: not held
- 2025 Q2: not held
- 2025 Q3: not held
- 2025 Q4: not held
- 2026 Q1: not held
- 2026 Q2: not held
- 2026 Q3: 198,227 shares, $134M, 1.4% of portfolio, New
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|